Biosimilar Interchangeability Does Not Equate To Substitution Under House Legislation
This article was originally published in The Pink Sheet Daily
Executive Summary
Bills from Rep. Waxman and Rep. Eshoo differ in their approaches, but both leave a lot of work to the states.